Incyte (INCY) is a publicly traded Healthcare sector company. As of May 20, 2026, INCY trades at $97.40 with a market cap of $19.02B and a P/E ratio of 36.15. INCY moved +1.56% today. Year to date, INCY is -5.74%; over the trailing twelve months it is +49.82%. Its 52-week range spans $53.56 to $112.29. Analyst consensus is buy with an average price target of $109.13. Rallies surfaces INCY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
INCY financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. INCY recently traded at $97.40. Market cap is $19.02B. P/E ratio is 36.15. Revenue is $3.70B.
| Metric | Value |
|---|---|
| Price | $97.40 |
| Market Cap | $19.02B |
| P/E Ratio | 36.15 |
| EPS | $2.67 |
| Dividend Yield | 0.00% |
| 52-Week High | $112.29 |
| 52-Week Low | $53.56 |
| Volume | 704.20K |
| Avg Volume | 0 |
| Revenue (TTM) | $3.70B |
| Net Income | $597.60M |
| Gross Margin | 93.10% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2023 | $3.70B | $597.60M | $2.67 |
| 2022 | $3.39B | $340.66M | $1.53 |
| 2021 | $2.99B | $948.58M | $4.30 |
| 2020 | $2.67B | $-295.70M | $-1.36 |
17 analysts cover INCY: 0 strong buy, 8 buy, 8 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $109.13.